Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study
- PMID: 15193681
- DOI: 10.1016/j.jacc.2003.11.064
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study
Abstract
Objectives: Our aim in this study was to determine whether increased left ventricular mass (LVM) is a risk factor for the development of a reduced left ventricular ejection fraction (LVEF).
Background: Prior studies have shown that increased LVM is a risk factor for heart failure but not whether it is a risk factor for a low LVEF.
Methods: As part of the Cardiovascular Health Study, a prospective population-based longitudinal study, we performed echocardiograms upon participant enrollment and again at follow-up of 4.9 +/- 0.14 years. In the present analysis, we identified 3,042 participants who had at baseline a normal LVEF and an assessment of LVM (either by electrocardiogram or echocardiogram), and at follow-up a measurable LVEF. The frequency of the development of a qualitatively depressed LVEF on two-dimensional echocardiography, corresponding approximately to an LVEF <55%, was analyzed by quartiles of baseline LVM. Multivariable regression determined whether LVM was independently associated with the development of depressed LVEF.
Results: Baseline quartile of echocardiographic LVM indexed to body surface area was associated with development of a depressed LVEF (4.8% in quartile 1, 4.4% in quartile 2, 7.5% in quartile 3, and 14.1% in quartile 4 [p < 0.001]). A similar relationship was seen in the subgroup of participants without myocardial infarction (p < 0.001). In multivariable regression that adjusted for confounders, both baseline echocardiographic (p < 0.001) and electrocardiographic (p < 0.001) LVM remained associated with development of depressed LVEF.
Conclusions: Increased LVM as assessed by electrocardiography or echocardiography is an independent risk factor for the development of depressed LVEF.
Comment in
-
Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?J Am Coll Cardiol. 2004 Jun 16;43(12):2216-8. doi: 10.1016/j.jacc.2004.03.024. J Am Coll Cardiol. 2004. PMID: 15193682 No abstract available.
Similar articles
-
Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.J Am Coll Cardiol. 2004 Jun 16;43(12):2200-6. doi: 10.1016/j.jacc.2003.10.073. J Am Coll Cardiol. 2004. PMID: 15193680 Clinical Trial.
-
Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.Echocardiography. 2014 Mar;31(3):325-34. doi: 10.1111/echo.12362. Epub 2013 Sep 10. Echocardiography. 2014. PMID: 24015855
-
Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up.Am J Cardiol. 2011 Oct 1;108(7):997-1001. doi: 10.1016/j.amjcard.2011.05.037. Epub 2011 Jul 27. Am J Cardiol. 2011. PMID: 21798496
-
Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis.Eur J Radiol. 2012 May;81(5):e757-62. doi: 10.1016/j.ejrad.2012.02.002. Epub 2012 Feb 29. Eur J Radiol. 2012. PMID: 22381439 Review.
-
Prognostic value of diastolic dysfunction: state of the art review.Cardiol Rev. 2014 Mar-Apr;22(2):79-90. doi: 10.1097/CRD.0b013e31829cf733. Cardiol Rev. 2014. PMID: 23707994 Review.
Cited by
-
Age-dependent hypertrophy and fibrosis dynamics in hypertrophic cardiomyopathy: Insights from longitudinal CMR studies.Int J Cardiol Heart Vasc. 2024 Oct 30;55:101546. doi: 10.1016/j.ijcha.2024.101546. eCollection 2024 Dec. Int J Cardiol Heart Vasc. 2024. PMID: 39555491 Free PMC article.
-
Genetic basis of right and left ventricular heart shape.Nat Commun. 2024 Nov 14;15(1):9437. doi: 10.1038/s41467-024-53594-7. Nat Commun. 2024. PMID: 39543113 Free PMC article.
-
Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated.Front Cardiovasc Med. 2024 Mar 13;11:1380506. doi: 10.3389/fcvm.2024.1380506. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38545338 Free PMC article.
-
Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.Acta Pharmacol Sin. 2024 Apr;45(4):738-750. doi: 10.1038/s41401-023-01191-7. Epub 2023 Dec 14. Acta Pharmacol Sin. 2024. PMID: 38097716
-
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease.Front Cardiovasc Med. 2023 Nov 2;10:1223635. doi: 10.3389/fcvm.2023.1223635. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38028489 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
